Cornercap Investment Counsel Inc. lowered its holdings in National Health Investors, Inc. (NYSE:NHI - Free Report) by 49.2% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,200 shares of the real estate investment trust's stock after selling 6,969 shares during the period. Cornercap Investment Counsel Inc.'s holdings in National Health Investors were worth $605,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in NHI. Vanguard Group Inc. raised its holdings in National Health Investors by 0.7% in the first quarter. Vanguard Group Inc. now owns 6,189,864 shares of the real estate investment trust's stock valued at $388,909,000 after acquiring an additional 43,520 shares in the last quarter. Lasalle Investment Management Securities LLC boosted its position in shares of National Health Investors by 8.4% during the 1st quarter. Lasalle Investment Management Securities LLC now owns 508,035 shares of the real estate investment trust's stock worth $31,920,000 after acquiring an additional 39,554 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. increased its holdings in shares of National Health Investors by 16.0% in the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 472,959 shares of the real estate investment trust's stock valued at $32,034,000 after acquiring an additional 65,104 shares during the last quarter. Land & Buildings Investment Management LLC raised its position in shares of National Health Investors by 4.6% during the 2nd quarter. Land & Buildings Investment Management LLC now owns 417,834 shares of the real estate investment trust's stock worth $28,300,000 after acquiring an additional 18,232 shares in the last quarter. Finally, Sound Income Strategies LLC lifted its stake in National Health Investors by 10.8% during the third quarter. Sound Income Strategies LLC now owns 169,582 shares of the real estate investment trust's stock worth $14,255,000 after purchasing an additional 16,463 shares during the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
NHI has been the topic of several research analyst reports. Bank of America assumed coverage on shares of National Health Investors in a research note on Tuesday, September 24th. They set a "buy" rating and a $92.00 price target on the stock. StockNews.com cut National Health Investors from a "buy" rating to a "hold" rating in a research report on Tuesday, October 15th. Truist Financial upped their target price on National Health Investors from $65.00 to $78.00 and gave the company a "hold" rating in a research report on Friday, August 30th. Finally, Wells Fargo & Company lowered National Health Investors from an "overweight" rating to an "equal weight" rating and lifted their price target for the stock from $81.00 to $86.00 in a research report on Tuesday, October 1st. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $73.29.
View Our Latest Stock Report on NHI
National Health Investors Stock Up 0.5 %
Shares of National Health Investors stock traded up $0.42 during trading on Friday, reaching $77.74. The company had a trading volume of 279,655 shares, compared to its average volume of 197,434. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. National Health Investors, Inc. has a fifty-two week low of $51.59 and a fifty-two week high of $86.13. The firm's fifty day moving average is $80.08 and its 200-day moving average is $73.90. The company has a market cap of $3.53 billion, a price-to-earnings ratio of 26.71, a price-to-earnings-growth ratio of 5.22 and a beta of 1.05.
National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing analysts' consensus estimates of $1.07 by ($0.42). National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The business had revenue of $63.32 million for the quarter, compared to the consensus estimate of $67.93 million. During the same period in the prior year, the company earned $1.08 EPS. National Health Investors's quarterly revenue was up 1.7% on a year-over-year basis. On average, analysts anticipate that National Health Investors, Inc. will post 4.42 EPS for the current year.
National Health Investors Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be given a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 4.63%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors's dividend payout ratio (DPR) is 123.71%.
National Health Investors Company Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Read More
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.